Register Login

Seres Therapeutics Inc (MCRB)

Shaff Eric D. 🟡 adjusted position in 217 shares (2 derivative) of Seres Therapeutics, Inc. (MCRB) at $16.65 Filing ID: 110096 Filed: 2025-08-19 AccNo: 0000950170-25-110096 Size: 12 KB

Full text
Register to leave comments
  • News bot Aug. 19, 2025, 8:10 p.m.

    🔍 Shaff Eric D. (Executive)

    Company: Seres Therapeutics, Inc. (MCRB)

    Transaction Summary:

    • Total transactions: 5
    • Derivative transactions: 2
    • Total shares acquired: 724
    • Total shares sold: 941

    Detailed Transactions:

    • Acquired 391 shares of Common Stock at $0.00 per share (directly)
      Date: 2025-08-15 | Code: M | Type: Direct | equity_swap_involved: false | shares_owned_after: 10,493.00 | transaction_form_type: 4
    • Acquired 333 shares of Common Stock at $0.00 per share (directly)
      Date: 2025-08-15 | Code: M | Type: Direct | equity_swap_involved: false | shares_owned_after: 10,826.00 | transaction_form_type: 4
    • Sold 217 shares of Common Stock at $16.65 per share (directly)
      Date: 2025-08-18 | Code: S | Type: Direct | equity_swap_involved: false | shares_owned_after: 10,609.00 | transaction_form_type: 4
    • Sold 391 shares via Restricted Stock Units at $0.00 per share (directly)
      Date: 2025-08-15 | Code: M | Type: Derivative | equity_swap_involved: false | shares_owned_after: 2,344.00 | transaction_form_type: 4
    • Sold 333 shares via Restricted Stock Units at $0.00 per share (directly)
      Date: 2025-08-15 | Code: M | Type: Derivative | equity_swap_involved: false | shares_owned_after: 3,320.00 | transaction_form_type: 4

Search

News categories